«For 20
years we have been using rational bioengineering to modify the chemical structures of clinically important natural products — using genetics to make a new molecule
in a process that parallels
medicinal chemistry — and that's what we were doing when we stumbled upon this,» said Professor Barrie Wilkinson from the John Innes Centre.